Products
Tools
Education
$15.59
$14.92
$28.54
$11.61
$824.8M
11.96%
This is a preview of the full version of Prosperse
Tyra Biosciences, a leading biotechnology company, has reached a new 52-week high of $21.67, reflecting its robust performance and investor confidence. The company has made progress in the development of its therapeutic candidate TYRA-300 for hypochondroplasia, with positive preclinical data present...
Investing.Com
Jul 23, 2024
Date: Nov 19, 2024
Date: Nov 14, 2024